Cargando…

Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months

The aim of the present study was to compare the clinical and economic benefits of intra-articular injections of platelet-rich plasma (PRP) and hyaluronic acid (HA) in Chinese patients with knee osteoarthritis (OA). A total of 86 patients (42 treated with PRP and 44 with HA) were treated with three w...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming, Huang, Zheyu, Wang, Shicheng, Di, Zhenglin, Zhang, Junhui, Liu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056115/
https://www.ncbi.nlm.nih.gov/pubmed/33884036
http://dx.doi.org/10.3892/etm.2021.10030
_version_ 1783680585676357632
author Li, Ming
Huang, Zheyu
Wang, Shicheng
Di, Zhenglin
Zhang, Junhui
Liu, Hua
author_facet Li, Ming
Huang, Zheyu
Wang, Shicheng
Di, Zhenglin
Zhang, Junhui
Liu, Hua
author_sort Li, Ming
collection PubMed
description The aim of the present study was to compare the clinical and economic benefits of intra-articular injections of platelet-rich plasma (PRP) and hyaluronic acid (HA) in Chinese patients with knee osteoarthritis (OA). A total of 86 patients (42 treated with PRP and 44 with HA) were treated with three weekly intra-articular injections. The inclusion criteria included patients between 18 and 75 years of age, with chronic knee pain or swelling lasting >3 months and X-ray findings of degenerative joint alterations according to the Kellgren-Lawrence score grade I-III. Clinical examinations were performed before treatment, at 1- and 6-month post-injection intervals. International Knee Documentation Committee subjective, Western Ontario and McMaster Universities and visual analogue scale scores were determined at each examination. Adverse reactions, average cost, treatment time and patient satisfaction were also recorded. Compared with patients injected with HA, PRP was found to be associated with increased and more severe post-injection pain and swelling, where the duration of adverse reactions was greater in the PRP group (P=0.02). During the follow-up evaluations, both groups showed statistically significant improvements in all clinical scores from pre-injection to 1- and 6-month assessments (P<0.05). However, no significant inter-group (PRP vs. HA) differences were observed in the clinical scores between the two follow-up time points. There were also no significant differences in clinical score between the groups with regards to the Kellgren-Lawrence grade I, II or III. The average cost of PRP injections was 22.8X that of HA administration and the average treatment time was 5X that of HA, but there was no significant difference in patient satisfaction. These preliminary results indicate that although PRP injections can significantly improve clinical outcome in patients with knee OA, PRP is not any more effective compared with HA. Furthermore, PRP injections are associated with higher costs and treatment times. Therefore, additional clinical studies are required before PRP injections can be considered as a first-line treatment option for knee OA.
format Online
Article
Text
id pubmed-8056115
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-80561152021-04-20 Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months Li, Ming Huang, Zheyu Wang, Shicheng Di, Zhenglin Zhang, Junhui Liu, Hua Exp Ther Med Articles The aim of the present study was to compare the clinical and economic benefits of intra-articular injections of platelet-rich plasma (PRP) and hyaluronic acid (HA) in Chinese patients with knee osteoarthritis (OA). A total of 86 patients (42 treated with PRP and 44 with HA) were treated with three weekly intra-articular injections. The inclusion criteria included patients between 18 and 75 years of age, with chronic knee pain or swelling lasting >3 months and X-ray findings of degenerative joint alterations according to the Kellgren-Lawrence score grade I-III. Clinical examinations were performed before treatment, at 1- and 6-month post-injection intervals. International Knee Documentation Committee subjective, Western Ontario and McMaster Universities and visual analogue scale scores were determined at each examination. Adverse reactions, average cost, treatment time and patient satisfaction were also recorded. Compared with patients injected with HA, PRP was found to be associated with increased and more severe post-injection pain and swelling, where the duration of adverse reactions was greater in the PRP group (P=0.02). During the follow-up evaluations, both groups showed statistically significant improvements in all clinical scores from pre-injection to 1- and 6-month assessments (P<0.05). However, no significant inter-group (PRP vs. HA) differences were observed in the clinical scores between the two follow-up time points. There were also no significant differences in clinical score between the groups with regards to the Kellgren-Lawrence grade I, II or III. The average cost of PRP injections was 22.8X that of HA administration and the average treatment time was 5X that of HA, but there was no significant difference in patient satisfaction. These preliminary results indicate that although PRP injections can significantly improve clinical outcome in patients with knee OA, PRP is not any more effective compared with HA. Furthermore, PRP injections are associated with higher costs and treatment times. Therefore, additional clinical studies are required before PRP injections can be considered as a first-line treatment option for knee OA. D.A. Spandidos 2021-06 2021-04-11 /pmc/articles/PMC8056115/ /pubmed/33884036 http://dx.doi.org/10.3892/etm.2021.10030 Text en Copyright: © Li et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Li, Ming
Huang, Zheyu
Wang, Shicheng
Di, Zhenglin
Zhang, Junhui
Liu, Hua
Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months
title Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months
title_full Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months
title_fullStr Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months
title_full_unstemmed Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months
title_short Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months
title_sort intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: preliminary follow-up results at 6-months
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056115/
https://www.ncbi.nlm.nih.gov/pubmed/33884036
http://dx.doi.org/10.3892/etm.2021.10030
work_keys_str_mv AT liming intraarticularinjectionsofplateletrichplasmavshyaluronicacidinpatientswithkneeosteoarthritispreliminaryfollowupresultsat6months
AT huangzheyu intraarticularinjectionsofplateletrichplasmavshyaluronicacidinpatientswithkneeosteoarthritispreliminaryfollowupresultsat6months
AT wangshicheng intraarticularinjectionsofplateletrichplasmavshyaluronicacidinpatientswithkneeosteoarthritispreliminaryfollowupresultsat6months
AT dizhenglin intraarticularinjectionsofplateletrichplasmavshyaluronicacidinpatientswithkneeosteoarthritispreliminaryfollowupresultsat6months
AT zhangjunhui intraarticularinjectionsofplateletrichplasmavshyaluronicacidinpatientswithkneeosteoarthritispreliminaryfollowupresultsat6months
AT liuhua intraarticularinjectionsofplateletrichplasmavshyaluronicacidinpatientswithkneeosteoarthritispreliminaryfollowupresultsat6months